Skip to main content
. 2021 Jul 14;189(3):787–796. doi: 10.1007/s10549-021-06326-0

Table 2.

Normalized graph measures at time points T1 and T2

Graph measure NC (n = 35) BCC − (n = 32) BCC + (n = 34) p
Cp T1 0.993 ± 0.002 0.992 ± 0.002 0.992 ± 0.002 0.996
T2 0.994 ± 0.003 0.993 ± 0.003 0.993 ± 0.003 0.285
Lp T1 1.218 ± 0.044 1.226 ± 0.043 1.213 ± 0.035 0.411
T2 1.196 ± 0.044 1.211 ± 0.037 1.209 ± 0.038 0.207
Eloc T1 0.986 ± 0.003 0.985 ± 0.002 0.986 ± 0.003 0.151
T2 0.988 ± 0.003 0.984 ± 0.003 0.986 ± 0.003 0.031
Eglob T1 0.867 ± 0.024 0.862 ± 0.021 0.871 ± 0.018 0.241
T2 0.880 ± 0.025 0.871 ± 0.019 0.871 ± 0.020 0.477

BCC − breast cancer patients with no chemotherapy, BCC + breast cancer patients receiving chemotherapy, NC non-cancer controls, Cp clustering coefficient, Lp characteristic path length, Eloc local efficiency, Eglob global efficiency

Values represent mean ± SD. Values were calculated after each participants’ network was normalized with random networks

Significance was declared by p < 0.05 and significant differences are highlighted in bold